Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs

Area of Science:

• Biochemistry
• Genetics
• Pathology

Background:

• Oxidative stress is a key factor in genomic instability and various diseases, including cancer and neurological disorders.
• Mitochondrial dysfunction (MDF) is implicated in these conditions due to mitochondria's role in energy metabolism and reactive oxygen/nitrogen species (RO/NS) production.
• Defective DNA damage and repair (DDR) pathways are linked to cancer predisposition and mitochondrial-related disorders.

Purpose of the Study:

• To review recent advancements in developing chemicals that improve mitochondrial function.
• To explore strategies for chemoprevention of MDF.
• To discuss future perspectives in targeting mitochondrial health for disease treatment.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of chemical compounds targeting mitochondrial function.
• Discussion of therapeutic strategies beyond simple RO/NS scavenging.

Main Results:

• Few compounds targeting RO/NS have shown therapeutic value.
• Emerging research focuses on drugs that enhance mitochondrial function or prevent MDF.
• Novel chemical approaches are being developed to address MDF-related disorders.

Conclusions:

• Targeting mitochondrial function is a promising therapeutic avenue.
• Developing drugs that improve mitochondrial health offers a new strategy for treating various diseases.
• Future research should focus on chemopreventive agents and functional mitochondrial enhancers.